» Articles » PMID: 31701076

Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI

Overview
Journal Hepatol Commun
Specialty Gastroenterology
Date 2019 Nov 9
PMID 31701076
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the liver glycogen phosphorylase () gene are associated with the diagnosis of glycogen storage disease type VI (GSD-VI). To understand the pathogenesis of GSD-VI, we generated a mouse model with deficiency ( ). mice exhibit hepatomegaly, excessive hepatic glycogen accumulation, and low hepatic free glucose along with lower fasting blood glucose levels and elevated blood ketone bodies. Hepatic glycogen accumulation in mice increases with age. Masson's trichrome and picrosirius red staining revealed minimal to mild collagen deposition in periportal, subcapsular, and/or perisinusoidal areas in the livers of old mice (>40 weeks). Consistently, immunohistochemical analysis showed the number of cells positive for alpha smooth muscle actin (α-SMA), a marker of activated hepatic stellate cells, was increased in the livers of old mice compared with those of age-matched wild-type (WT) mice. Furthermore, old mice had inflammatory infiltrates associated with hepatic vessels in their livers along with up-regulated hepatic messenger RNA levels of C-C chemokine ligand 5 (/) and monocyte chemoattractant protein 1 (), indicating inflammation, while age-matched WT mice did not. Serum levels of aspartate aminotransferase and alanine aminotransferase were elevated in old mice, indicating liver damage. : deficiency results in progressive accumulation of hepatic glycogen with age and liver damage, inflammation, and collagen deposition, which can increase the risk of liver fibrosis. Collectively, the -deficient mouse recapitulates clinical features in patients with GSD-VI and provides a model to elucidate the mechanisms underlying hepatic complications associated with defective glycogen metabolism.

Citing Articles

Liquid-liquid phase separation in hepatocellular carcinoma.

Xu J, Liu W, Yao Y, Knowles T, Zhang Z, Zhang Y Front Cell Dev Biol. 2025; 12():1454587.

PMID: 39777266 PMC: 11703843. DOI: 10.3389/fcell.2024.1454587.


Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX γ2 models human disease.

Gibson R, Jeck W, Koch R, Mehta A, Choi S, Sriraman Y Mol Genet Metab. 2024; 143(4):108597.

PMID: 39488079 PMC: 11633833. DOI: 10.1016/j.ymgme.2024.108597.


Adaptive Strategies and Underlying Response Mechanisms of Ciliates to Salinity Change with Note on Fluctuation Properties.

Li F, Yang J, Li J, Lin X Microorganisms. 2024; 12(10).

PMID: 39458267 PMC: 11509147. DOI: 10.3390/microorganisms12101957.


Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.

Ren L, Lu R, Fei X, Chen S, Liu P, Zhu C J Cancer Res Clin Oncol. 2024; 150(3):127.

PMID: 38483604 PMC: 10940407. DOI: 10.1007/s00432-024-05644-2.


Unlocking the Antioxidant Potential of White Tea and Osmanthus Flower: A Novel Polyphenol Liquid Preparation and Its Impact on KM Mice and Their Offspring.

Wang Y, Xu J, Fan Z, Zhou X, Wang Z, Zhang H Foods. 2023; 12(21).

PMID: 37959160 PMC: 10650671. DOI: 10.3390/foods12214041.


References
1.
Burwinkel B, Bakker H, Herschkovitz E, Moses S, Shin Y, Kilimann M . Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet. 1998; 62(4):785-91. PMC: 1377030. DOI: 10.1086/301790. View

2.
Liu K, Wu J, Chen Y . Mouse model of glycogen storage disease type III. Mol Genet Metab. 2014; 111(4):467-76. DOI: 10.1016/j.ymgme.2014.02.005. View

3.
Beauchamp N, Taybert J, Champion M, Layet V, Heinz-Erian P, Dalton A . High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis. 2007; 30(5):722-34. DOI: 10.1007/s10545-007-0499-9. View

4.
Chang S, Rosenberg M, Morton H, Francomano C, Biesecker L . Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet. 1998; 7(5):865-70. DOI: 10.1093/hmg/7.5.865. View

5.
Testa G, Schaft J, van der Hoeven F, Glaser S, Anastassiadis K, Zhang Y . A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. Genesis. 2004; 38(3):151-8. DOI: 10.1002/gene.20012. View